Shares of Japan’s Eisai tumble after EU rejects Alzheimer’s drug EP News Bureau Jul 29, 2024 EU regulator cites brain swelling risks, impacting Eisai and Biogen, and sparking concerns over global sales and market perception…
AstraZeneca’s COVID prevention drug application gets EU fast-track assessment Reuters Jul 1, 2024 An accelerated assessment aims to speed up the European Medicines Agency’s (EMA) review of a market authorisation application
